173 related articles for article (PubMed ID: 30194166)
1. Cell Subpopulations Overexpressing p75NTR Have Tumor-initiating Properties in the C6 Glioma Cell Line.
Yang WH; Cheng CY; Chen MF; Wang TC
Anticancer Res; 2018 Sep; 38(9):5183-5192. PubMed ID: 30194166
[TBL] [Abstract][Full Text] [Related]
2. Modulation of p75 neurotrophin receptor under hypoxic conditions induces migration and invasion of C6 glioma cells.
Wang TC; Luo SJ; Lin CL; Chang PJ; Chen MF
Clin Exp Metastasis; 2015 Jan; 32(1):73-81. PubMed ID: 25527128
[TBL] [Abstract][Full Text] [Related]
3. Enhanced cancer stem cell properties of a mitotically quiescent subpopulation of p75NTR-positive cells in esophageal squamous cell carcinoma.
Kojima H; Okumura T; Yamaguchi T; Miwa T; Shimada Y; Nagata T
Int J Oncol; 2017 Jul; 51(1):49-62. PubMed ID: 28534989
[TBL] [Abstract][Full Text] [Related]
4. p75 neurotrophin receptor: A potential surface marker of tongue squamous cell carcinoma stem cells.
Tong D; Sun J; Huang P; Li M; Zhang F
Mol Med Rep; 2017 May; 15(5):2521-2529. PubMed ID: 28447720
[TBL] [Abstract][Full Text] [Related]
5. p75 neurotrophin receptor cleavage by α- and γ-secretases is required for neurotrophin-mediated proliferation of brain tumor-initiating cells.
Forsyth PA; Krishna N; Lawn S; Valadez JG; Qu X; Fenstermacher DA; Fournier M; Potthast L; Chinnaiyan P; Gibney GT; Zeinieh M; Barker PA; Carter BD; Cooper MK; Kenchappa RS
J Biol Chem; 2014 Mar; 289(12):8067-85. PubMed ID: 24519935
[TBL] [Abstract][Full Text] [Related]
6. The low-affinity nerve growth factor receptor p75NTR identifies a transient stem cell-like state in oral squamous cell carcinoma cells.
Osman TA; Parajuli H; Sapkota D; Ahmed IA; Johannessen ACh; Costea DE
J Oral Pathol Med; 2015 Jul; 44(6):410-9. PubMed ID: 25212757
[TBL] [Abstract][Full Text] [Related]
7. CXCR4-positive subset of glioma is enriched for cancer stem cells.
Zheng X; Xie Q; Li S; Zhang W
Oncol Res; 2011; 19(12):555-61. PubMed ID: 22812188
[TBL] [Abstract][Full Text] [Related]
8. 1,25-Dihydroxyvitamin D3 regulates the expression of the low-affinity neurotrophin receptor.
Naveilhan P; Neveu I; Baudet C; Funakoshi H; Wion D; Brachet P; Metsis M
Brain Res Mol Brain Res; 1996 Sep; 41(1-2):259-68. PubMed ID: 8883959
[TBL] [Abstract][Full Text] [Related]
9. The Role of Neurotrophin Signaling in Gliomagenesis: A Focus on the p75 Neurotrophin Receptor (p75
Alshehri MM; Robbins SM; Senger DL
Vitam Horm; 2017; 104():367-404. PubMed ID: 28215302
[TBL] [Abstract][Full Text] [Related]
10. p75 neurotrophin receptor expression is a characteristic of the mitotically quiescent cancer stem cell population present in esophageal squamous cell carcinoma.
Yamaguchi T; Okumura T; Hirano K; Watanabe T; Nagata T; Shimada Y; Tsukada K
Int J Oncol; 2016 May; 48(5):1943-54. PubMed ID: 26984177
[TBL] [Abstract][Full Text] [Related]
11. ProBDNF and its receptors are upregulated in glioma and inhibit the growth of glioma cells in vitro.
Xiong J; Zhou L; Yang M; Lim Y; Zhu YH; Fu DL; Li ZW; Zhong JH; Xiao ZC; Zhou XF
Neuro Oncol; 2013 Aug; 15(8):990-1007. PubMed ID: 23576602
[TBL] [Abstract][Full Text] [Related]
12. Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions.
Fang KM; Lin TC; Chan TC; Ma SZ; Tzou BC; Chang WR; Liu JJ; Chiou SH; Yang CS; Tzeng SF
Glia; 2013 Sep; 61(9):1402-17. PubMed ID: 23832679
[TBL] [Abstract][Full Text] [Related]
13. 3D bioprinted glioma stem cells for brain tumor model and applications of drug susceptibility.
Dai X; Ma C; Lan Q; Xu T
Biofabrication; 2016 Oct; 8(4):045005. PubMed ID: 27725343
[TBL] [Abstract][Full Text] [Related]
14. ABCG2 regulates self-renewal and stem cell marker expression but not tumorigenicity or radiation resistance of glioma cells.
Wee B; Pietras A; Ozawa T; Bazzoli E; Podlaha O; Antczak C; Westermark B; Nelander S; Uhrbom L; Forsberg-Nilsson K; Djaballah H; Michor F; Holland EC
Sci Rep; 2016 Jul; 6():25956. PubMed ID: 27456282
[TBL] [Abstract][Full Text] [Related]
15. CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas.
Bexell D; Gunnarsson S; Siesjö P; Bengzon J; Darabi A
Int J Cancer; 2009 Jul; 125(1):15-22. PubMed ID: 19291792
[TBL] [Abstract][Full Text] [Related]
16. Flow Cytometric Detection of Circulating Tumor Cells Using a Candidate Stem Cell Marker, p75 Neurotrophin Receptor (p75NTR).
Okumura T; Yamaguchi T; Watanabe T; Nagata T; Shimada Y
Methods Mol Biol; 2017; 1634():211-217. PubMed ID: 28819854
[TBL] [Abstract][Full Text] [Related]
17. Self-renewal and chemotherapy resistance of p75NTR positive cells in esophageal squamous cell carcinomas.
Huang SD; Yuan Y; Liu XH; Gong DJ; Bai CG; Wang F; Luo JH; Xu ZY
BMC Cancer; 2009 Jan; 9():9. PubMed ID: 19134212
[TBL] [Abstract][Full Text] [Related]
18. CNTF receptor subunit α as a marker for glioma tumor-initiating cells and tumor grade: laboratory investigation.
Lu J; Ksendzovsky A; Yang C; Mehta GU; Yong RL; Weil RJ; Park DM; Mushlin HM; Fang X; Balgley BM; Lee DH; Lee CS; Lonser RR; Zhuang Z
J Neurosurg; 2012 Dec; 117(6):1022-1031. PubMed ID: 23061382
[TBL] [Abstract][Full Text] [Related]
19. [Effect of IL-24 gene expression on the growth of glioma cells in vitro and in vivo].
Li WL; Shan BE; Yan YL; Zheng LF; Li QX; Zhou NJ; Zhao WQ
Zhonghua Zhong Liu Za Zhi; 2005 Mar; 27(3):141-4. PubMed ID: 15946561
[TBL] [Abstract][Full Text] [Related]
20. Clinical Relevance of a Candidate Stem Cell Marker, p75 Neurotrophin Receptor (p75NTR) Expression in Circulating Tumor Cells.
Okumura T; Yamaguchi T; Watanabe T; Nagata T; Shimada Y
Adv Exp Med Biol; 2017; 994():247-254. PubMed ID: 28560678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
